Review decisions
Showing 10 results of 2109 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1701460825795
Product Type: Drug
Control Number: 278519
Manufacturer: Novavax Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2023-08-31
Decision / Authorization Date: 2023-12-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1701354245768
Product Type: Drug
Control Number: 267444
DIN(s): 02542714
Manufacturer: Sanofi Pasteur Limited
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-08-29
Decision / Authorization Date: 2023-10-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1700599569568
Product Type: Drug
Control Number: 274515
DIN(s): 02523434
Manufacturer: GlaxoSmithKline Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-04-19
Decision / Authorization Date: 2023-11-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1702060641808
Product Type: Drug
Control Number: 268742
DIN(s): 02543036, 02543044
Manufacturer: Jamp Pharma Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-12-01
Decision / Authorization Date: 2023-11-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1698933880208
Product Type: Drug
Control Number: 268334
DIN(s): 02401347
Manufacturer: Seagen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-10-03
Decision / Authorization Date: 2023-09-13
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1699548065621
Product Type: Drug
Control Number: 269852
DIN(s): 02491559, 02533448, 02533456
Manufacturer: Alexion Pharma GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-11-17
Decision / Authorization Date: 2023-10-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1699385708073
Product Type: Drug
Control Number: 273721
DIN(s): 02542560
Manufacturer: CSL Behring Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2023-03-27
Decision / Authorization Date: 2023-10-23
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1697629380576
DIN(s): 02404508, 02420201, 02493586, 02493594, 02494809, 02494817, 02495341, 02495368, 02497026, 02497034, 02502690, 02502704, 02505762, 02505770, 02513781, 02513803, 02515563, 02515571, 02516047, 02516055, 02540746, 02540754
Issued / Original Publication Date: 2023-10-27
Updated Date: 2023-10-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1697811489202
Product Type: Drug
Control Number: 268288
DIN(s): 02542250
Manufacturer: Teva Canada Limited
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-10-04
Decision / Authorization Date: 2023-10-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1699032842238
Product Type: Drug
Control Number: 271331
DIN(s): 02542293, 02542307
Manufacturer: AbbVie Corporation
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2023-01-12
Decision / Authorization Date: 2023-10-13